Literature DB >> 12554148

Liquid chromatography for iothalamate in biological samples.

Rajiv Agarwal1, Nina Vasavada, Shawn D Chase.   

Abstract

We have previously reported an iothalamate assay for the assessment of the glomerular filtration rate (GFR) that required a long column equilibration time and 22 min run time per sample. We now report a simpler assay that requires a run time of only 5.5 min and is more precise and accurate than the earlier technique. The mobile phase consisted of methanol-acetonitrile-50 mM sodium monobasic phosphate (10:5:85, v/v) at pH 4.4, pumped at a rate of 1.5 ml/min on a C(18) reversed-phase column. Samples of plasma and urine were deproteinized with 1 volume of 4% perchloric acid or 9 volumes of 2% perchloric acid, respectively. No internal standard was used. The diode array detection system collected absorbance at 240 nm and the peak height areas of iothalamate were determined. The iothalamate peak appeared at 3.5 min. Detector response was linear over the range tested (10-2000 microg/ml). Within-run precision was <3% for both plasma and urine and accuracy was 96-102%. Between-day precision for plasma and urine analyses were <7%. The recovery of iothalamate in urine and plasma were 102% and 91%, respectively. There was excellent thermal and pH stability of iothalamate. No interference was found with para-amino hippuric acid (PAH) or N-acetyl PAH, which can be simultaneously assayed, if desired. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12554148     DOI: 10.1016/s1570-0232(02)00960-1

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  7 in total

1.  Assessment of renal function in clinical practice at the bedside of burn patients.

Authors:  J M Conil; B Georges; O Fourcade; T Seguin; M Lavit; K Samii; G Houin; I Tack; S Saivin
Journal:  Br J Clin Pharmacol       Date:  2006-12-07       Impact factor: 4.335

2.  Assessment of renal function before contrast media injection: right decisions based on inaccurate estimates.

Authors:  Václav Ptáčník; David Zogala; Daniela Skibová; Hana Jiskrová; Jiří Trnka; Vladimír Tesař; Romana Ryšavá; Martin Šámal
Journal:  Eur Radiol       Date:  2018-11-09       Impact factor: 5.315

3.  Use of dried plasma spots for the quantification of iothalamate in clinical studies.

Authors:  Andrew S Hagan; David R Jones; Rajiv Agarwal
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-14       Impact factor: 8.237

4.  Assessment of iothalamate plasma clearance: duration of study affects quality of GFR.

Authors:  Rajiv Agarwal; Jennifer E Bills; Paulos M Yigazu; Terri Abraham; Andinet B Gizaw; Robert P Light; Dagim M Bekele; Getachew G Tegegne
Journal:  Clin J Am Soc Nephrol       Date:  2008-11-12       Impact factor: 8.237

5.  Smoking, oxidative stress and inflammation: impact on resting energy expenditure in diabetic nephropathy.

Authors:  Rajiv Agarwal
Journal:  BMC Nephrol       Date:  2005-11-22       Impact factor: 2.388

6.  A randomized trial of intravenous and oral iron in chronic kidney disease.

Authors:  Rajiv Agarwal; John W Kusek; Maria K Pappas
Journal:  Kidney Int       Date:  2015-06-17       Impact factor: 10.612

7.  HPLC estimation of iothalamate to measure glomerular filtration rate in humans.

Authors:  Iltaf Shah; James Barker; Declan P Naughton; Stephen J Barton; Syed Salman Ashraf
Journal:  Chem Cent J       Date:  2016-12-12       Impact factor: 4.215

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.